Home › Funds › Royce & Associates › ABSI
Royce & Associates position in ABSI
ABSCI CORPORATION · Health Care
Latest position (Q2 2026)445.78K sh
Reported value held$5.17M
Portfolio Weight0.04%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 387.77K | $1.63M | New |
| Q1 2024 | 132.01K | $749.82K | Reduce |
| Q2 2024 | 192.49K | $592.88K | Add |
| Q3 2024 | 154.19K | $589.01K | Reduce |
| Q4 2024 | 882.10K | $2.31M | Add |
| Q1 2025 | 1.22M | $3.06M | Add |
| Q2 2025 | 1.52M | $3.90M | Add |
| Q3 2025 | 1.26M | $3.83M | Reduce |
| Q4 2025 | 735.35K | $2.57M | Reduce |
| Q1 2026 | 735.35K | $2.21M | Hold |
| Q2 2026 | 445.78K | $5.17M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABSI
- Fidelity Management & Research (FMR) 25.41M sh · $294.50M · Q2 2026
- ARK Invest 12.93M sh · $149.80M · Q2 2026
- BlackRock Inc 12.18M sh · $141.11M · Q2 2026
- Two Sigma Investments 5.49M sh · $63.67M · Q2 2026
- D. E. Shaw & Co 5.24M sh · $60.73M · Q2 2026
- Geode Capital Management 3.58M sh · $41.54M · Q2 2026
- Vanguard Group 7.91M sh · $27.61M · Q4 2025
- Goldman Sachs Group 1.73M sh · $20.08M · Q2 2026
- Morgan Stanley 1.37M sh · $15.93M · Q2 2026
- Charles Schwab Investment Management 1.17M sh · $13.51M · Q2 2026
- UBS Group AG 1.14M sh · $13.20M · Q2 2026
- Northern Trust Corp 1.11M sh · $12.89M · Q2 2026